nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—ADRA2C—Brimonidine—glaucoma	0.0731	0.0976	CbGbCtD
Mianserin—ADRA2C—Apraclonidine—glaucoma	0.0731	0.0976	CbGbCtD
Mianserin—ADRA2B—Brimonidine—glaucoma	0.0693	0.0926	CbGbCtD
Mianserin—ADRA2B—Apraclonidine—glaucoma	0.0693	0.0926	CbGbCtD
Mianserin—ADRA2C—Dipivefrin—glaucoma	0.0584	0.0781	CbGbCtD
Mianserin—ADRA2B—Dipivefrin—glaucoma	0.0554	0.074	CbGbCtD
Mianserin—ADRA2A—Brimonidine—glaucoma	0.0482	0.0644	CbGbCtD
Mianserin—ADRA2A—Apraclonidine—glaucoma	0.0482	0.0644	CbGbCtD
Mianserin—ADRA2A—Dipivefrin—glaucoma	0.0385	0.0515	CbGbCtD
Mianserin—ADRA2C—Clonidine—glaucoma	0.0303	0.0405	CbGbCtD
Mianserin—ADRA2B—Clonidine—glaucoma	0.0288	0.0385	CbGbCtD
Mianserin—SLC6A2—Clonidine—glaucoma	0.0222	0.0297	CbGbCtD
Mianserin—ADRA2A—Clonidine—glaucoma	0.02	0.0267	CbGbCtD
Mianserin—CYP2D6—Carteolol—glaucoma	0.018	0.024	CbGbCtD
Mianserin—CYP1A2—Betaxolol—glaucoma	0.0147	0.0197	CbGbCtD
Mianserin—CYP2D6—Betaxolol—glaucoma	0.0121	0.0162	CbGbCtD
Mianserin—CYP2D6—Methazolamide—glaucoma	0.00921	0.0123	CbGbCtD
Mianserin—CYP3A4—Pilocarpine—glaucoma	0.00867	0.0116	CbGbCtD
Mianserin—CYP1A2—Clonidine—glaucoma	0.00808	0.0108	CbGbCtD
Mianserin—CYP2D6—Timolol—glaucoma	0.00783	0.0105	CbGbCtD
Mianserin—CYP3A4—Brinzolamide—glaucoma	0.0068	0.00909	CbGbCtD
Mianserin—CYP2D6—Clonidine—glaucoma	0.00666	0.0089	CbGbCtD
Mianserin—CYP3A4—Dorzolamide—glaucoma	0.00657	0.00878	CbGbCtD
Mianserin—CYP3A4—Methazolamide—glaucoma	0.00585	0.00782	CbGbCtD
Mianserin—CYP3A4—Acetazolamide—glaucoma	0.00468	0.00625	CbGbCtD
Mianserin—CYP3A4—Clonidine—glaucoma	0.00423	0.00566	CbGbCtD
Mianserin—Amitriptyline—NTRK2—glaucoma	0.000762	0.618	CrCbGaD
Mianserin—Amitriptyline—NTRK1—glaucoma	0.000471	0.382	CrCbGaD
Mianserin—Erectile dysfunction—Betaxolol—glaucoma	0.000345	0.00193	CcSEcCtD
Mianserin—Agitation—Pilocarpine—glaucoma	0.000345	0.00193	CcSEcCtD
Mianserin—Hepatitis—Clonidine—glaucoma	0.000344	0.00192	CcSEcCtD
Mianserin—Hypertension—Dorzolamide—glaucoma	0.000343	0.00192	CcSEcCtD
Mianserin—Rash—Carbachol—glaucoma	0.000341	0.00191	CcSEcCtD
Mianserin—Hypertension—Travoprost—glaucoma	0.000341	0.00191	CcSEcCtD
Mianserin—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000341	0.00191	CcSEcCtD
Mianserin—Dermatitis—Carbachol—glaucoma	0.000341	0.00191	CcSEcCtD
Mianserin—Fatigue—Apraclonidine—glaucoma	0.000341	0.00191	CcSEcCtD
Mianserin—Weight increased—Betaxolol—glaucoma	0.00034	0.00191	CcSEcCtD
Mianserin—Somnolence—Bimatoprost—glaucoma	0.00034	0.00191	CcSEcCtD
Mianserin—Oedema—Brimonidine—glaucoma	0.000339	0.0019	CcSEcCtD
Mianserin—Headache—Carbachol—glaucoma	0.000339	0.0019	CcSEcCtD
Mianserin—Arthralgia—Dorzolamide—glaucoma	0.000338	0.00189	CcSEcCtD
Mianserin—Constipation—Apraclonidine—glaucoma	0.000338	0.00189	CcSEcCtD
Mianserin—Hypertension—Brinzolamide—glaucoma	0.000337	0.00188	CcSEcCtD
Mianserin—Arthralgia—Travoprost—glaucoma	0.000336	0.00188	CcSEcCtD
Mianserin—Myalgia—Travoprost—glaucoma	0.000336	0.00188	CcSEcCtD
Mianserin—Cardiac arrest—Timolol—glaucoma	0.000336	0.00188	CcSEcCtD
Mianserin—Syncope—Pilocarpine—glaucoma	0.000336	0.00188	CcSEcCtD
Mianserin—Leukopenia—Pilocarpine—glaucoma	0.000336	0.00188	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000334	0.00187	CcSEcCtD
Mianserin—Headache—Levobunolol—glaucoma	0.000334	0.00187	CcSEcCtD
Mianserin—Shock—Brimonidine—glaucoma	0.000334	0.00187	CcSEcCtD
Mianserin—Nervous system disorder—Brimonidine—glaucoma	0.000333	0.00186	CcSEcCtD
Mianserin—Arthralgia—Brinzolamide—glaucoma	0.000332	0.00186	CcSEcCtD
Mianserin—Myalgia—Brinzolamide—glaucoma	0.000332	0.00186	CcSEcCtD
Mianserin—Tachycardia—Brimonidine—glaucoma	0.000331	0.00185	CcSEcCtD
Mianserin—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000331	0.00185	CcSEcCtD
Mianserin—Dry mouth—Dorzolamide—glaucoma	0.00033	0.00185	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00033	0.00185	CcSEcCtD
Mianserin—Loss of consciousness—Pilocarpine—glaucoma	0.00033	0.00184	CcSEcCtD
Mianserin—Skin disorder—Brimonidine—glaucoma	0.000329	0.00184	CcSEcCtD
Mianserin—Dry mouth—Travoprost—glaucoma	0.000329	0.00184	CcSEcCtD
Mianserin—Dizziness—Latanoprost—glaucoma	0.000327	0.00183	CcSEcCtD
Mianserin—Confusional state—Dorzolamide—glaucoma	0.000327	0.00183	CcSEcCtD
Mianserin—Feeling abnormal—Apraclonidine—glaucoma	0.000325	0.00182	CcSEcCtD
Mianserin—Dry mouth—Brinzolamide—glaucoma	0.000325	0.00182	CcSEcCtD
Mianserin—Oedema—Dorzolamide—glaucoma	0.000324	0.00181	CcSEcCtD
Mianserin—Hypertension—Pilocarpine—glaucoma	0.000324	0.00181	CcSEcCtD
Mianserin—Oedema—Travoprost—glaucoma	0.000322	0.0018	CcSEcCtD
Mianserin—Rash—Methazolamide—glaucoma	0.000322	0.0018	CcSEcCtD
Mianserin—Dermatitis—Methazolamide—glaucoma	0.000322	0.0018	CcSEcCtD
Mianserin—Eye disorder—Clonidine—glaucoma	0.000321	0.0018	CcSEcCtD
Mianserin—Tinnitus—Clonidine—glaucoma	0.000321	0.00179	CcSEcCtD
Mianserin—Headache—Methazolamide—glaucoma	0.00032	0.00179	CcSEcCtD
Mianserin—Breast disorder—Timolol—glaucoma	0.00032	0.00179	CcSEcCtD
Mianserin—Cardiac disorder—Clonidine—glaucoma	0.000319	0.00179	CcSEcCtD
Mianserin—Arthralgia—Pilocarpine—glaucoma	0.000319	0.00179	CcSEcCtD
Mianserin—Myalgia—Pilocarpine—glaucoma	0.000319	0.00179	CcSEcCtD
Mianserin—Shock—Dorzolamide—glaucoma	0.000319	0.00178	CcSEcCtD
Mianserin—Paraesthesia—Acetazolamide—glaucoma	0.000317	0.00178	CcSEcCtD
Mianserin—Hypotension—Brimonidine—glaucoma	0.000317	0.00177	CcSEcCtD
Mianserin—Nervous system disorder—Travoprost—glaucoma	0.000316	0.00177	CcSEcCtD
Mianserin—Tachycardia—Travoprost—glaucoma	0.000315	0.00176	CcSEcCtD
Mianserin—Somnolence—Acetazolamide—glaucoma	0.000314	0.00176	CcSEcCtD
Mianserin—Skin disorder—Travoprost—glaucoma	0.000313	0.00175	CcSEcCtD
Mianserin—Nervous system disorder—Brinzolamide—glaucoma	0.000312	0.00175	CcSEcCtD
Mianserin—Angiopathy—Clonidine—glaucoma	0.000312	0.00175	CcSEcCtD
Mianserin—Rash—Latanoprost—glaucoma	0.000312	0.00174	CcSEcCtD
Mianserin—Agranulocytosis—Betaxolol—glaucoma	0.000311	0.00174	CcSEcCtD
Mianserin—Dermatitis—Latanoprost—glaucoma	0.000311	0.00174	CcSEcCtD
Mianserin—Tachycardia—Brinzolamide—glaucoma	0.000311	0.00174	CcSEcCtD
Mianserin—Mediastinal disorder—Clonidine—glaucoma	0.00031	0.00173	CcSEcCtD
Mianserin—Headache—Latanoprost—glaucoma	0.00031	0.00173	CcSEcCtD
Mianserin—Skin disorder—Brinzolamide—glaucoma	0.000309	0.00173	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000309	0.00173	CcSEcCtD
Mianserin—Confusional state—Pilocarpine—glaucoma	0.000309	0.00173	CcSEcCtD
Mianserin—Oedema—Pilocarpine—glaucoma	0.000306	0.00171	CcSEcCtD
Mianserin—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000305	0.00171	CcSEcCtD
Mianserin—Bradycardia—Betaxolol—glaucoma	0.000305	0.00171	CcSEcCtD
Mianserin—Fatigue—Acetazolamide—glaucoma	0.000305	0.0017	CcSEcCtD
Mianserin—Paraesthesia—Brimonidine—glaucoma	0.000304	0.0017	CcSEcCtD
Mianserin—Hypotension—Dorzolamide—glaucoma	0.000303	0.00169	CcSEcCtD
Mianserin—Somnolence—Brimonidine—glaucoma	0.000301	0.00169	CcSEcCtD
Mianserin—Mental disorder—Clonidine—glaucoma	0.000301	0.00169	CcSEcCtD
Mianserin—Hypotension—Travoprost—glaucoma	0.000301	0.00169	CcSEcCtD
Mianserin—Shock—Pilocarpine—glaucoma	0.000301	0.00168	CcSEcCtD
Mianserin—Thrombocytopenia—Pilocarpine—glaucoma	0.0003	0.00168	CcSEcCtD
Mianserin—Tachycardia—Pilocarpine—glaucoma	0.000299	0.00167	CcSEcCtD
Mianserin—Hypotension—Brinzolamide—glaucoma	0.000297	0.00166	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000295	0.00165	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Travoprost—glaucoma	0.000294	0.00164	CcSEcCtD
Mianserin—Gastrointestinal disorder—Brimonidine—glaucoma	0.000293	0.00164	CcSEcCtD
Mianserin—Fatigue—Brimonidine—glaucoma	0.000292	0.00164	CcSEcCtD
Mianserin—Feeling abnormal—Acetazolamide—glaucoma	0.000291	0.00163	CcSEcCtD
Mianserin—Paraesthesia—Dorzolamide—glaucoma	0.000291	0.00163	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.00029	0.00162	CcSEcCtD
Mianserin—Somnolence—Dorzolamide—glaucoma	0.000288	0.00161	CcSEcCtD
Mianserin—Hypotension—Pilocarpine—glaucoma	0.000286	0.0016	CcSEcCtD
Mianserin—Paraesthesia—Brinzolamide—glaucoma	0.000286	0.0016	CcSEcCtD
Mianserin—Asthenia—Apraclonidine—glaucoma	0.000283	0.00159	CcSEcCtD
Mianserin—Somnolence—Brinzolamide—glaucoma	0.000283	0.00158	CcSEcCtD
Mianserin—Erectile dysfunction—Timolol—glaucoma	0.000281	0.00158	CcSEcCtD
Mianserin—Tremor—Clonidine—glaucoma	0.000281	0.00157	CcSEcCtD
Mianserin—Eye disorder—Betaxolol—glaucoma	0.00028	0.00157	CcSEcCtD
Mianserin—Pruritus—Apraclonidine—glaucoma	0.000279	0.00156	CcSEcCtD
Mianserin—Fatigue—Dorzolamide—glaucoma	0.000279	0.00156	CcSEcCtD
Mianserin—Tinnitus—Betaxolol—glaucoma	0.000279	0.00156	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000279	0.00156	CcSEcCtD
Mianserin—Gastrointestinal disorder—Travoprost—glaucoma	0.000278	0.00156	CcSEcCtD
Mianserin—Fatigue—Travoprost—glaucoma	0.000278	0.00156	CcSEcCtD
Mianserin—Cardiac disorder—Betaxolol—glaucoma	0.000278	0.00156	CcSEcCtD
Mianserin—Constipation—Travoprost—glaucoma	0.000276	0.00154	CcSEcCtD
Mianserin—Agitation—Clonidine—glaucoma	0.000275	0.00154	CcSEcCtD
Mianserin—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000275	0.00154	CcSEcCtD
Mianserin—Paraesthesia—Pilocarpine—glaucoma	0.000275	0.00154	CcSEcCtD
Mianserin—Asthenia—Bimatoprost—glaucoma	0.000275	0.00154	CcSEcCtD
Mianserin—Fatigue—Brinzolamide—glaucoma	0.000274	0.00154	CcSEcCtD
Mianserin—Somnolence—Pilocarpine—glaucoma	0.000272	0.00152	CcSEcCtD
Mianserin—Angiopathy—Betaxolol—glaucoma	0.000272	0.00152	CcSEcCtD
Mianserin—Pruritus—Bimatoprost—glaucoma	0.000271	0.00152	CcSEcCtD
Mianserin—Mediastinal disorder—Betaxolol—glaucoma	0.00027	0.00151	CcSEcCtD
Mianserin—Syncope—Clonidine—glaucoma	0.000268	0.0015	CcSEcCtD
Mianserin—Feeling abnormal—Dorzolamide—glaucoma	0.000267	0.00149	CcSEcCtD
Mianserin—Feeling abnormal—Travoprost—glaucoma	0.000266	0.00149	CcSEcCtD
Mianserin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000264	0.00148	CcSEcCtD
Mianserin—Loss of consciousness—Clonidine—glaucoma	0.000263	0.00147	CcSEcCtD
Mianserin—Feeling abnormal—Brinzolamide—glaucoma	0.000262	0.00147	CcSEcCtD
Mianserin—Mental disorder—Betaxolol—glaucoma	0.000262	0.00147	CcSEcCtD
Mianserin—Constipation—Pilocarpine—glaucoma	0.000262	0.00146	CcSEcCtD
Mianserin—Dizziness—Apraclonidine—glaucoma	0.000261	0.00146	CcSEcCtD
Mianserin—Arthralgia—Clonidine—glaucoma	0.000255	0.00143	CcSEcCtD
Mianserin—Agranulocytosis—Timolol—glaucoma	0.000254	0.00142	CcSEcCtD
Mianserin—Asthenia—Acetazolamide—glaucoma	0.000253	0.00142	CcSEcCtD
Mianserin—Dizziness—Bimatoprost—glaucoma	0.000253	0.00142	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000253	0.00142	CcSEcCtD
Mianserin—Feeling abnormal—Pilocarpine—glaucoma	0.000252	0.00141	CcSEcCtD
Mianserin—Dry mouth—Clonidine—glaucoma	0.000249	0.0014	CcSEcCtD
Mianserin—Bradycardia—Timolol—glaucoma	0.000249	0.00139	CcSEcCtD
Mianserin—Dermatitis—Apraclonidine—glaucoma	0.000249	0.00139	CcSEcCtD
Mianserin—Headache—Apraclonidine—glaucoma	0.000247	0.00138	CcSEcCtD
Mianserin—Confusional state—Clonidine—glaucoma	0.000246	0.00138	CcSEcCtD
Mianserin—Oedema—Clonidine—glaucoma	0.000244	0.00137	CcSEcCtD
Mianserin—Tremor—Betaxolol—glaucoma	0.000244	0.00137	CcSEcCtD
Mianserin—Asthenia—Brimonidine—glaucoma	0.000243	0.00136	CcSEcCtD
Mianserin—Rash—Bimatoprost—glaucoma	0.000241	0.00135	CcSEcCtD
Mianserin—Dermatitis—Bimatoprost—glaucoma	0.000241	0.00135	CcSEcCtD
Mianserin—Anaemia—Betaxolol—glaucoma	0.000241	0.00135	CcSEcCtD
Mianserin—Shock—Clonidine—glaucoma	0.00024	0.00135	CcSEcCtD
Mianserin—Connective tissue disorder—Timolol—glaucoma	0.00024	0.00135	CcSEcCtD
Mianserin—Pruritus—Brimonidine—glaucoma	0.00024	0.00134	CcSEcCtD
Mianserin—Headache—Bimatoprost—glaucoma	0.00024	0.00134	CcSEcCtD
Mianserin—Nervous system disorder—Clonidine—glaucoma	0.00024	0.00134	CcSEcCtD
Mianserin—Thrombocytopenia—Clonidine—glaucoma	0.000239	0.00134	CcSEcCtD
Mianserin—Tachycardia—Clonidine—glaucoma	0.000238	0.00133	CcSEcCtD
Mianserin—Skin disorder—Clonidine—glaucoma	0.000237	0.00133	CcSEcCtD
Mianserin—Vertigo—Betaxolol—glaucoma	0.000234	0.00131	CcSEcCtD
Mianserin—Syncope—Betaxolol—glaucoma	0.000234	0.00131	CcSEcCtD
Mianserin—Dizziness—Acetazolamide—glaucoma	0.000234	0.00131	CcSEcCtD
Mianserin—Asthenia—Dorzolamide—glaucoma	0.000232	0.0013	CcSEcCtD
Mianserin—Asthenia—Travoprost—glaucoma	0.000231	0.00129	CcSEcCtD
Mianserin—Pruritus—Dorzolamide—glaucoma	0.000229	0.00128	CcSEcCtD
Mianserin—Loss of consciousness—Betaxolol—glaucoma	0.000229	0.00128	CcSEcCtD
Mianserin—Eye disorder—Timolol—glaucoma	0.000229	0.00128	CcSEcCtD
Mianserin—Asthenia—Brinzolamide—glaucoma	0.000228	0.00128	CcSEcCtD
Mianserin—Hypotension—Clonidine—glaucoma	0.000228	0.00128	CcSEcCtD
Mianserin—Pruritus—Travoprost—glaucoma	0.000228	0.00128	CcSEcCtD
Mianserin—Tinnitus—Timolol—glaucoma	0.000228	0.00128	CcSEcCtD
Mianserin—Cardiac disorder—Timolol—glaucoma	0.000227	0.00127	CcSEcCtD
Mianserin—Pruritus—Brinzolamide—glaucoma	0.000225	0.00126	CcSEcCtD
Mianserin—Dizziness—Brimonidine—glaucoma	0.000224	0.00125	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Clonidine—glaucoma	0.000223	0.00125	CcSEcCtD
Mianserin—Angiopathy—Timolol—glaucoma	0.000222	0.00124	CcSEcCtD
Mianserin—Arthralgia—Betaxolol—glaucoma	0.000222	0.00124	CcSEcCtD
Mianserin—Myalgia—Betaxolol—glaucoma	0.000222	0.00124	CcSEcCtD
Mianserin—Headache—Acetazolamide—glaucoma	0.000221	0.00124	CcSEcCtD
Mianserin—Mediastinal disorder—Timolol—glaucoma	0.00022	0.00123	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00022	0.00123	CcSEcCtD
Mianserin—Asthenia—Pilocarpine—glaucoma	0.00022	0.00123	CcSEcCtD
Mianserin—Paraesthesia—Clonidine—glaucoma	0.000219	0.00123	CcSEcCtD
Mianserin—Somnolence—Clonidine—glaucoma	0.000217	0.00122	CcSEcCtD
Mianserin—Dry mouth—Betaxolol—glaucoma	0.000217	0.00121	CcSEcCtD
Mianserin—Pruritus—Pilocarpine—glaucoma	0.000216	0.00121	CcSEcCtD
Mianserin—Confusional state—Betaxolol—glaucoma	0.000215	0.0012	CcSEcCtD
Mianserin—Mental disorder—Timolol—glaucoma	0.000214	0.0012	CcSEcCtD
Mianserin—Dizziness—Dorzolamide—glaucoma	0.000214	0.0012	CcSEcCtD
Mianserin—Rash—Brimonidine—glaucoma	0.000214	0.0012	CcSEcCtD
Mianserin—Dermatitis—Brimonidine—glaucoma	0.000214	0.0012	CcSEcCtD
Mianserin—Dizziness—Travoprost—glaucoma	0.000213	0.00119	CcSEcCtD
Mianserin—Oedema—Betaxolol—glaucoma	0.000213	0.00119	CcSEcCtD
Mianserin—Headache—Brimonidine—glaucoma	0.000212	0.00119	CcSEcCtD
Mianserin—Gastrointestinal disorder—Clonidine—glaucoma	0.000211	0.00118	CcSEcCtD
Mianserin—Fatigue—Clonidine—glaucoma	0.000211	0.00118	CcSEcCtD
Mianserin—Dizziness—Brinzolamide—glaucoma	0.000211	0.00118	CcSEcCtD
Mianserin—Shock—Betaxolol—glaucoma	0.000209	0.00117	CcSEcCtD
Mianserin—Constipation—Clonidine—glaucoma	0.000209	0.00117	CcSEcCtD
Mianserin—Nervous system disorder—Betaxolol—glaucoma	0.000209	0.00117	CcSEcCtD
Mianserin—Thrombocytopenia—Betaxolol—glaucoma	0.000208	0.00117	CcSEcCtD
Mianserin—Tachycardia—Betaxolol—glaucoma	0.000208	0.00116	CcSEcCtD
Mianserin—Skin disorder—Betaxolol—glaucoma	0.000207	0.00116	CcSEcCtD
Mianserin—Rash—Dorzolamide—glaucoma	0.000204	0.00114	CcSEcCtD
Mianserin—Dermatitis—Dorzolamide—glaucoma	0.000204	0.00114	CcSEcCtD
Mianserin—Rash—Travoprost—glaucoma	0.000203	0.00114	CcSEcCtD
Mianserin—Dermatitis—Travoprost—glaucoma	0.000203	0.00114	CcSEcCtD
Mianserin—Headache—Dorzolamide—glaucoma	0.000203	0.00114	CcSEcCtD
Mianserin—Dizziness—Pilocarpine—glaucoma	0.000202	0.00113	CcSEcCtD
Mianserin—Headache—Travoprost—glaucoma	0.000202	0.00113	CcSEcCtD
Mianserin—Feeling abnormal—Clonidine—glaucoma	0.000201	0.00113	CcSEcCtD
Mianserin—Rash—Brinzolamide—glaucoma	0.000201	0.00112	CcSEcCtD
Mianserin—Dermatitis—Brinzolamide—glaucoma	0.000201	0.00112	CcSEcCtD
Mianserin—Headache—Brinzolamide—glaucoma	0.000199	0.00112	CcSEcCtD
Mianserin—Hypotension—Betaxolol—glaucoma	0.000199	0.00111	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000194	0.00108	CcSEcCtD
Mianserin—Rash—Pilocarpine—glaucoma	0.000193	0.00108	CcSEcCtD
Mianserin—Dermatitis—Pilocarpine—glaucoma	0.000193	0.00108	CcSEcCtD
Mianserin—Headache—Pilocarpine—glaucoma	0.000192	0.00107	CcSEcCtD
Mianserin—Vertigo—Timolol—glaucoma	0.000191	0.00107	CcSEcCtD
Mianserin—Paraesthesia—Betaxolol—glaucoma	0.000191	0.00107	CcSEcCtD
Mianserin—Syncope—Timolol—glaucoma	0.000191	0.00107	CcSEcCtD
Mianserin—Loss of consciousness—Timolol—glaucoma	0.000187	0.00105	CcSEcCtD
Mianserin—Hypertension—Timolol—glaucoma	0.000184	0.00103	CcSEcCtD
Mianserin—Gastrointestinal disorder—Betaxolol—glaucoma	0.000184	0.00103	CcSEcCtD
Mianserin—Fatigue—Betaxolol—glaucoma	0.000183	0.00103	CcSEcCtD
Mianserin—Constipation—Betaxolol—glaucoma	0.000182	0.00102	CcSEcCtD
Mianserin—Myalgia—Timolol—glaucoma	0.000181	0.00101	CcSEcCtD
Mianserin—Arthralgia—Timolol—glaucoma	0.000181	0.00101	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00018	0.00101	CcSEcCtD
Mianserin—Dry mouth—Timolol—glaucoma	0.000177	0.000992	CcSEcCtD
Mianserin—Asthenia—Clonidine—glaucoma	0.000175	0.000981	CcSEcCtD
Mianserin—Feeling abnormal—Betaxolol—glaucoma	0.000175	0.000981	CcSEcCtD
Mianserin—Confusional state—Timolol—glaucoma	0.000175	0.000981	CcSEcCtD
Mianserin—Oedema—Timolol—glaucoma	0.000174	0.000973	CcSEcCtD
Mianserin—Pruritus—Clonidine—glaucoma	0.000173	0.000968	CcSEcCtD
Mianserin—Shock—Timolol—glaucoma	0.000171	0.000957	CcSEcCtD
Mianserin—Nervous system disorder—Timolol—glaucoma	0.00017	0.000954	CcSEcCtD
Mianserin—Skin disorder—Timolol—glaucoma	0.000169	0.000945	CcSEcCtD
Mianserin—Hypotension—Timolol—glaucoma	0.000162	0.000909	CcSEcCtD
Mianserin—Dizziness—Clonidine—glaucoma	0.000162	0.000904	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Timolol—glaucoma	0.000158	0.000886	CcSEcCtD
Mianserin—Paraesthesia—Timolol—glaucoma	0.000156	0.000873	CcSEcCtD
Mianserin—Somnolence—Timolol—glaucoma	0.000155	0.000865	CcSEcCtD
Mianserin—Rash—Clonidine—glaucoma	0.000154	0.000862	CcSEcCtD
Mianserin—Dermatitis—Clonidine—glaucoma	0.000154	0.000861	CcSEcCtD
Mianserin—Headache—Clonidine—glaucoma	0.000153	0.000857	CcSEcCtD
Mianserin—Asthenia—Betaxolol—glaucoma	0.000153	0.000854	CcSEcCtD
Mianserin—Pruritus—Betaxolol—glaucoma	0.000151	0.000842	CcSEcCtD
Mianserin—Gastrointestinal disorder—Timolol—glaucoma	0.00015	0.00084	CcSEcCtD
Mianserin—Fatigue—Timolol—glaucoma	0.00015	0.000839	CcSEcCtD
Mianserin—Feeling abnormal—Timolol—glaucoma	0.000143	0.000802	CcSEcCtD
Mianserin—Dizziness—Betaxolol—glaucoma	0.000141	0.000787	CcSEcCtD
Mianserin—Rash—Betaxolol—glaucoma	0.000134	0.000751	CcSEcCtD
Mianserin—Dermatitis—Betaxolol—glaucoma	0.000134	0.00075	CcSEcCtD
Mianserin—Headache—Betaxolol—glaucoma	0.000133	0.000746	CcSEcCtD
Mianserin—Asthenia—Timolol—glaucoma	0.000125	0.000698	CcSEcCtD
Mianserin—Pruritus—Timolol—glaucoma	0.000123	0.000688	CcSEcCtD
Mianserin—Dizziness—Timolol—glaucoma	0.000115	0.000643	CcSEcCtD
Mianserin—Rash—Timolol—glaucoma	0.00011	0.000613	CcSEcCtD
Mianserin—Dermatitis—Timolol—glaucoma	0.000109	0.000613	CcSEcCtD
Mianserin—Headache—Timolol—glaucoma	0.000109	0.000609	CcSEcCtD
Mianserin—ADRA2B—Signaling Pathways—NTRK1—glaucoma	9.86e-06	0.000137	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—C3—glaucoma	9.85e-06	0.000137	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—C3—glaucoma	9.78e-06	0.000136	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—ABCA1—glaucoma	9.78e-06	0.000136	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CYP1B1—glaucoma	9.78e-06	0.000136	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NGFR—glaucoma	9.69e-06	0.000135	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EDN1—glaucoma	9.65e-06	0.000135	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—GSTM1—glaucoma	9.63e-06	0.000134	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CA2—glaucoma	9.57e-06	0.000133	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NGF—glaucoma	9.54e-06	0.000133	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NTRK1—glaucoma	9.52e-06	0.000133	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NTRK1—glaucoma	9.47e-06	0.000132	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—APOE—glaucoma	9.38e-06	0.000131	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—MMP9—glaucoma	9.34e-06	0.00013	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—CDKN1B—glaucoma	9.31e-06	0.00013	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CAV1—glaucoma	9.29e-06	0.000129	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—APOE—glaucoma	9.24e-06	0.000129	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—APOE—glaucoma	9.23e-06	0.000129	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NTRK1—glaucoma	9.21e-06	0.000128	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—APOE—glaucoma	9.17e-06	0.000128	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NTRK2—glaucoma	9.17e-06	0.000128	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CYP1B1—glaucoma	9.17e-06	0.000128	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ABCA1—glaucoma	9.17e-06	0.000128	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CAV1—glaucoma	9.16e-06	0.000128	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CAV1—glaucoma	9.15e-06	0.000127	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CAV1—glaucoma	9.09e-06	0.000127	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CDKN2B—glaucoma	9.08e-06	0.000127	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—C3—glaucoma	9.06e-06	0.000126	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—NOS3—glaucoma	9.03e-06	0.000126	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NGF—glaucoma	8.87e-06	0.000124	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—FN1—glaucoma	8.85e-06	0.000123	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NGFR—glaucoma	8.79e-06	0.000123	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CDKN2B—glaucoma	8.77e-06	0.000122	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—BAD—glaucoma	8.74e-06	0.000122	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—TXN—glaucoma	8.74e-06	0.000122	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CDKN2B—glaucoma	8.72e-06	0.000122	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—FN1—glaucoma	8.72e-06	0.000121	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EDN1—glaucoma	8.72e-06	0.000121	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—FN1—glaucoma	8.71e-06	0.000121	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NGFR—glaucoma	8.65e-06	0.000121	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—FN1—glaucoma	8.65e-06	0.000121	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NGFR—glaucoma	8.63e-06	0.00012	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MMP9—glaucoma	8.62e-06	0.00012	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—BAD—glaucoma	8.61e-06	0.00012	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—BAD—glaucoma	8.61e-06	0.00012	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—VEGFA—glaucoma	8.56e-06	0.000119	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—BAD—glaucoma	8.55e-06	0.000119	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—TP53—glaucoma	8.53e-06	0.000119	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—MTHFR—glaucoma	8.51e-06	0.000119	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CDKN2B—glaucoma	8.49e-06	0.000118	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—APOE—glaucoma	8.44e-06	0.000118	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—C3—glaucoma	8.43e-06	0.000118	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EDN1—glaucoma	8.41e-06	0.000117	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—VEGFA—glaucoma	8.39e-06	0.000117	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EDN1—glaucoma	8.37e-06	0.000117	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CAV1—glaucoma	8.36e-06	0.000116	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NTRK1—glaucoma	8.35e-06	0.000116	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NTRK1—glaucoma	8.22e-06	0.000115	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NTRK1—glaucoma	8.2e-06	0.000114	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EDN1—glaucoma	8.14e-06	0.000113	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NGF—glaucoma	8.01e-06	0.000112	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GSTT1—glaucoma	8e-06	0.000111	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.97e-06	0.000111	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—TP53—glaucoma	7.97e-06	0.000111	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—FN1—glaucoma	7.96e-06	0.000111	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—APOE—glaucoma	7.92e-06	0.00011	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.9e-06	0.00011	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NGFR—glaucoma	7.87e-06	0.00011	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—BAD—glaucoma	7.86e-06	0.00011	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—APOE—glaucoma	7.85e-06	0.000109	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—CAV1—glaucoma	7.85e-06	0.000109	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CDKN1B—glaucoma	7.82e-06	0.000109	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—GSTM1—glaucoma	7.82e-06	0.000109	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CAV1—glaucoma	7.78e-06	0.000108	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—VEGFA—glaucoma	7.74e-06	0.000108	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NGF—glaucoma	7.73e-06	0.000108	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CDKN2B—glaucoma	7.7e-06	0.000107	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NGF—glaucoma	7.69e-06	0.000107	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—C3—glaucoma	7.61e-06	0.000106	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CDKN2B—glaucoma	7.58e-06	0.000106	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CDKN2B—glaucoma	7.56e-06	0.000105	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NGF—glaucoma	7.48e-06	0.000104	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NTRK1—glaucoma	7.48e-06	0.000104	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—FN1—glaucoma	7.4e-06	0.000103	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EDN1—glaucoma	7.39e-06	0.000103	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—C3—glaucoma	7.35e-06	0.000102	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—GSTM1—glaucoma	7.33e-06	0.000102	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—BAD—glaucoma	7.32e-06	0.000102	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—C3—glaucoma	7.31e-06	0.000102	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EDN1—glaucoma	7.27e-06	0.000101	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EDN1—glaucoma	7.25e-06	0.000101	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MMP9—glaucoma	7.25e-06	0.000101	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—C3—glaucoma	7.11e-06	9.91e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—APOE—glaucoma	7.09e-06	9.88e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NOS3—glaucoma	7.03e-06	9.79e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CAV1—glaucoma	7.02e-06	9.79e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NOS3—glaucoma	6.93e-06	9.65e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NOS3—glaucoma	6.92e-06	9.64e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—MTHFR—glaucoma	6.91e-06	9.63e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	6.89e-06	9.6e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NOS3—glaucoma	6.87e-06	9.58e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—APOE—glaucoma	6.84e-06	9.53e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—APOE—glaucoma	6.81e-06	9.49e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NGF—glaucoma	6.79e-06	9.46e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CAV1—glaucoma	6.78e-06	9.45e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTT1—glaucoma	6.78e-06	9.44e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CAV1—glaucoma	6.75e-06	9.4e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TXN—glaucoma	6.74e-06	9.4e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—FN1—glaucoma	6.69e-06	9.31e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NGF—glaucoma	6.68e-06	9.31e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NGF—glaucoma	6.67e-06	9.29e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—APOE—glaucoma	6.62e-06	9.23e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EDN1—glaucoma	6.61e-06	9.21e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—BAD—glaucoma	6.61e-06	9.2e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CAV1—glaucoma	6.56e-06	9.14e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—VEGFA—glaucoma	6.51e-06	9.06e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—MTHFR—glaucoma	6.48e-06	9.02e-05	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TP53—glaucoma	6.47e-06	9.01e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—C3—glaucoma	6.45e-06	8.99e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—FN1—glaucoma	6.45e-06	8.99e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—APOE—glaucoma	6.43e-06	8.96e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—FN1—glaucoma	6.42e-06	8.94e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—BAD—glaucoma	6.38e-06	8.88e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CAV1—glaucoma	6.37e-06	8.88e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CYP1B1—glaucoma	6.37e-06	8.88e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ABCA1—glaucoma	6.37e-06	8.88e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—C3—glaucoma	6.35e-06	8.85e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—BAD—glaucoma	6.34e-06	8.84e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TP53—glaucoma	6.34e-06	8.83e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—C3—glaucoma	6.34e-06	8.83e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NOS3—glaucoma	6.32e-06	8.81e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—FN1—glaucoma	6.24e-06	8.7e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—BAD—glaucoma	6.17e-06	8.6e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CDKN1B—glaucoma	6.09e-06	8.48e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NGF—glaucoma	6.08e-06	8.47e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—APOE—glaucoma	6.03e-06	8.4e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—APOE—glaucoma	6.01e-06	8.37e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CDKN1B—glaucoma	6e-06	8.36e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CDKN1B—glaucoma	5.99e-06	8.35e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CAV1—glaucoma	5.98e-06	8.32e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CDKN1B—glaucoma	5.95e-06	8.3e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CAV1—glaucoma	5.95e-06	8.29e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—NOS3—glaucoma	5.93e-06	8.27e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—APOE—glaucoma	5.91e-06	8.24e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—APOE—glaucoma	5.9e-06	8.22e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NOS3—glaucoma	5.88e-06	8.2e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CAV1—glaucoma	5.86e-06	8.16e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TP53—glaucoma	5.85e-06	8.15e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CAV1—glaucoma	5.84e-06	8.14e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—C3—glaucoma	5.78e-06	8.05e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—FN1—glaucoma	5.67e-06	7.89e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MMP9—glaucoma	5.64e-06	7.86e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—BAD—glaucoma	5.6e-06	7.8e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—FN1—glaucoma	5.58e-06	7.77e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—FN1—glaucoma	5.56e-06	7.75e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MMP9—glaucoma	5.56e-06	7.74e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MMP9—glaucoma	5.55e-06	7.73e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MMP9—glaucoma	5.51e-06	7.68e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—BAD—glaucoma	5.51e-06	7.68e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—BAD—glaucoma	5.5e-06	7.66e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CDKN1B—glaucoma	5.48e-06	7.63e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.46e-06	7.61e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PTGS2—glaucoma	5.43e-06	7.56e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CYP1B1—glaucoma	5.4e-06	7.52e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ABCA1—glaucoma	5.4e-06	7.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—APOE—glaucoma	5.38e-06	7.49e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CAV1—glaucoma	5.33e-06	7.42e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NOS3—glaucoma	5.31e-06	7.4e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTT1—glaucoma	5.23e-06	7.29e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NOS3—glaucoma	5.13e-06	7.14e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NOS3—glaucoma	5.1e-06	7.11e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CDKN1B—glaucoma	5.1e-06	7.1e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GSTM1—glaucoma	5.09e-06	7.1e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MMP9—glaucoma	5.07e-06	7.07e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—FN1—glaucoma	5.07e-06	7.07e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—VEGFA—glaucoma	5.06e-06	7.05e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—BAD—glaucoma	5.01e-06	6.98e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—VEGFA—glaucoma	4.99e-06	6.95e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—VEGFA—glaucoma	4.98e-06	6.94e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NOS3—glaucoma	4.96e-06	6.91e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—glaucoma	4.95e-06	6.9e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—glaucoma	4.92e-06	6.85e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—NOS3—glaucoma	4.82e-06	6.71e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MMP9—glaucoma	4.72e-06	6.58e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	4.6e-06	6.41e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—glaucoma	4.55e-06	6.35e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—NOS3—glaucoma	4.52e-06	6.29e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MTHFR—glaucoma	4.5e-06	6.27e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NOS3—glaucoma	4.5e-06	6.27e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CDKN1B—glaucoma	4.44e-06	6.19e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NOS3—glaucoma	4.43e-06	6.17e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NOS3—glaucoma	4.42e-06	6.16e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CDKN1B—glaucoma	4.42e-06	6.16e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTGS2—glaucoma	4.41e-06	6.14e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTM1—glaucoma	4.32e-06	6.01e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	4.3e-06	5.99e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—glaucoma	4.26e-06	5.94e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—glaucoma	4.24e-06	5.9e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOE—glaucoma	4.19e-06	5.84e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ABCA1—glaucoma	4.17e-06	5.8e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP1B1—glaucoma	4.17e-06	5.8e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CAV1—glaucoma	4.15e-06	5.79e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTGS2—glaucoma	4.13e-06	5.76e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—glaucoma	4.11e-06	5.73e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—glaucoma	4.09e-06	5.7e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOS3—glaucoma	4.03e-06	5.61e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—glaucoma	3.98e-06	5.55e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CDKN1B—glaucoma	3.9e-06	5.43e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CDKN1B—glaucoma	3.84e-06	5.35e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CDKN1B—glaucoma	3.83e-06	5.33e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—glaucoma	3.83e-06	5.33e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—glaucoma	3.83e-06	5.33e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—glaucoma	3.81e-06	5.31e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—glaucoma	3.77e-06	5.25e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—glaucoma	3.77e-06	5.25e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—glaucoma	3.74e-06	5.21e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—glaucoma	3.69e-06	5.15e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—glaucoma	3.67e-06	5.12e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—glaucoma	3.61e-06	5.03e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—glaucoma	3.57e-06	4.98e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—glaucoma	3.55e-06	4.95e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOE—glaucoma	3.55e-06	4.95e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—glaucoma	3.55e-06	4.94e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAV1—glaucoma	3.52e-06	4.9e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	3.49e-06	4.86e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—glaucoma	3.44e-06	4.79e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTM1—glaucoma	3.33e-06	4.64e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—glaucoma	3.24e-06	4.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—glaucoma	3.23e-06	4.5e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—glaucoma	3.2e-06	4.46e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—glaucoma	3.19e-06	4.45e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—glaucoma	3.18e-06	4.44e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NOS3—glaucoma	3.14e-06	4.37e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—glaucoma	2.94e-06	4.1e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—glaucoma	2.9e-06	4.04e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—glaucoma	2.89e-06	4.03e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—glaucoma	2.87e-06	4e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—glaucoma	2.79e-06	3.89e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—glaucoma	2.78e-06	3.87e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOE—glaucoma	2.74e-06	3.82e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAV1—glaucoma	2.72e-06	3.78e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—glaucoma	2.7e-06	3.76e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NOS3—glaucoma	2.66e-06	3.71e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—glaucoma	2.45e-06	3.41e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—glaucoma	2.43e-06	3.39e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—glaucoma	2.41e-06	3.36e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—glaucoma	2.41e-06	3.35e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—glaucoma	2.19e-06	3.06e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NOS3—glaucoma	2.05e-06	2.86e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—glaucoma	1.88e-06	2.62e-05	CbGpPWpGaD
